Evaluating dexamethasone intraocular suspension 9% post-cataract surgery
Alex Delaney-Gesing
Cathleen McCabe, MD, shares an overview of results from a retrospective study highlighting the effectiveness of dexamethasone intraocular suspension 9% following cataract surgery.
Cathleen McCabe, MD, of The Eye Associates, shares an overview of results from a retrospective study highlighting the effectiveness of dexamethasone intraocular suspension 9% following cataract surgery.
Read the article highlights:
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Articles
- Q&A: Anat Loewenstein recaps the 2025 EURETINA meeting
September 22nd 2025
- Q&A: Robyn Guymer highlights risk factors of intermediate AMD
September 20th 2025
- Investigators share positive results of DAVIO 2 trial at EURETINA 2025
September 18th 2025